Journal of the American Academy of Dermatology
Volume 62, Issue 3 , Pages 393-397 , March 2010

Efficacy and safety of mycophenolate mofetil for lichen planopilaris

  • Bryan K. Cho, MD, PhD

      Affiliations

    • Department of Dermatology, Palo Alto Medical Foundation, Mountain View, California
  • ,
  • Deborah Sah, MD

      Affiliations

    • Urgent Care, Palo Alto Medical Foundation, Fremont, California
  • ,
  • Jennifer Chwalek, MD

      Affiliations

    • Department of Dermatology, Kaiser Medical Group, Union City, California
  • ,
  • Ingrid Roseborough, MD

      Affiliations

    • Department of Dermatology, University of Iowa Hospitals and Clinics, Iowa City, Iowa
  • ,
  • Blanca Ochoa, MD

      Affiliations

    • Department of Dermatology, Baylor College of Medicine, Houston, Texas
  • ,
  • Charles Chiang, MD

      Affiliations

    • Department of Dermatology, University of California, San Francisco, California
  • ,
  • Vera H. Price, MD

      Affiliations

    • Department of Dermatology, University of California, San Francisco, California
    • Corresponding Author InformationReprint requests: Vera H. Price, MD, Department of Dermatology, University of California, San Francisco, 1701 Divisadero St, Third Floor, San Francisco, CA 94143.

,Accepted 3 May 2009.

References 

  1. Whiting DA. Cicatricial alopecia: clinico-pathological findings and treatment. Clin Dermatol. 2001;19:211–225
  2. Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol. 1992;27:935–942
  3. Mirmirani P, Willey A, Price VH. Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol. 2003;49:667–671
  4. Ho VC, Gupta AK, Ellis CN, Nickoloff BJ, Voorhees JJ. Treatment of severe lichen planus with cyclosporine. J Am Acad Dermatol. 1990;22:64–68
  5. Price VH. The medical treatment of cicatricial alopecia. Semin Cutan Med Surg. 2006;25:56–59
  6. Cribier B, Frances C, Chosidow O. Treatment of lichen planus: an evidence-based medicine analysis of efficacy. Arch Dermatol. 1998;134:1521–1530
  7. Buell C, Koo J. Long-term safety of mycophenolate mofetil and cyclosporine: a review. J Drugs Dermatol. 2008;7:741–748
  8. Tan E, Martinka M, Ball N, Shapiro J. Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol. 2004;50:25–32
  9. Zwerner J, Fiorentino D. Mycophenolate mofetil. Dermatol Ther. 2007;20:229–238
  10. Liu V, Mackool BT. Mycophenolate in dermatology. J Dermatolog Treat. 2003;14:203–211
  11. Dalmau J, Puig L, Roe E, Peramiquel L, Campos M, Alomar A. Successful treatment of oral erosive lichen planus with mycophenolate mofetil. J Eur Acad Dermatol Venereol. 2007;21:259–260
  12. Nousari HC, Goyal S, Anhalt GJ. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil. Arch Dermatol. 1999;135:1420–1421
  13. Frieling U, Bonsmann G, Schwarz T, Luger TA, Beissert S. Treatment of severe lichen planus with mycophenolate mofetil. J Am Acad Dermatol. 2003;49:1063–1066
  14. Tursen U, Api H, Kaya T, Ikizoglu G. Treatment of lichen planopilaris with mycophenolate mofetil. Dermatol Online J. 2004;10:24

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(09)00605-7

doi: 10.1016/j.jaad.2009.05.018

Journal of the American Academy of Dermatology
Volume 62, Issue 3 , Pages 393-397 , March 2010